Toronto Dominion Bank Travere Therapeutics, Inc. Transaction History

Toronto Dominion Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$17.82 - $22.89 $53 - $68	3 New	3 $0
Q2 2022 Aug 11, 2022	BUY	$20.94 - $30.01 $1,005 - $1,440	48 New	48 $1,000
Q1 2022 May 09, 2022	SELL	$23.61 - $30.6 $1.86 Million - $2.42 Million	-78,942 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$24.34 - $31.17 $1.92 Million - $2.46 Million	78,942 New	78,942 $2.45 Million

198

84.9M

776K

912K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.